Zimmer Biomet (ZBH) Competitors

GE HealthCare Technologies (NASDAQ:GEHC) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Do insiders and institutionals hold more shares of GEHC or ZBH?

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, GEHC or ZBH?

GE HealthCare Technologies has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.

Is GEHC or ZBH more profitable?

Zimmer Biomet has a net margin of 11.86% compared to GE HealthCare Technologies' net margin of 11.02%. GE HealthCare Technologies' return on equity of 24.95% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	11.02%	24.95%	6.38%
Zimmer Biomet	11.86%	12.73%	7.34%

Which has stronger valuation and earnings, GEHC or ZBH?

GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$19.67B	1.77	$1.99B	$4.75	16.03
Zimmer Biomet	$7.68B	2.41	$903.70M	$4.52	20.69

Do analysts prefer GEHC or ZBH?

GE HealthCare Technologies currently has a consensus price target of $88.27, indicating a potential upside of 15.97%. Zimmer Biomet has a consensus price target of $111.33, indicating a potential upside of 19.07%. Given Zimmer Biomet's higher probable upside, analysts plainly believe Zimmer Biomet is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
Zimmer Biomet	2 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.30

Does the media favor GEHC or ZBH?

In the previous week, GE HealthCare Technologies had 4 more articles in the media than Zimmer Biomet. MarketBeat recorded 26 mentions for GE HealthCare Technologies and 22 mentions for Zimmer Biomet. GE HealthCare Technologies' average media sentiment score of 1.28 beat Zimmer Biomet's score of 0.69 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	19 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	11 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is GEHC or ZBH a better dividend stock?

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.0%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Zimmer Biomet pays out 21.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

Summary

GE HealthCare Technologies beats Zimmer Biomet on 11 of the 19 factors compared between the two stocks.